- Trials with a EudraCT protocol (480)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (4)
480 result(s) found for: Pharmacological Treatment.
Displaying page 1 of 24.
EudraCT Number: 2006-000954-31 | Sponsor Protocol Number: D3560L00006 | Start Date*: 2006-05-05 |
Sponsor Name:AstraZeneca Oy | ||
Full Title: Centralised Pan-European Survey on the Undertreatment of Hyperchlesterolemia | ||
Medical condition: Patients on lipid-lowering pharmacological treatment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-001260-29 | Sponsor Protocol Number: 2012-CARDAF | Start Date*: 2012-04-24 | |||||||||||
Sponsor Name:FONDAZIONE ISTITUTO SAN RAFFAELE-G.GIGLIO | |||||||||||||
Full Title: Identification of predictive plasma Biomarkers and use of a high dosage statin during a procedure of Parrossistic Atrial Fibrillation pharmacological Cardioversion | |||||||||||||
Medical condition: Parossistic Atrial Fibrillation according to the European Socierty of Cardiology (ESC)criteria | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002637-37 | Sponsor Protocol Number: NL66693.058.18 | Start Date*: 2020-06-29 |
Sponsor Name:Leiden University | ||
Full Title: Manipulating NMDA-dependent learning to alter nocebo effects: A pharmacological fMRI study on pain and itch. | ||
Medical condition: Nocebo effects on pain and itch | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001384-11 | Sponsor Protocol Number: captaf | Start Date*: 2008-04-03 | |||||||||||
Sponsor Name: | |||||||||||||
Full Title: Catheter Ablation compared with Pharmacological Therapy for Atrial Fibrillation – the CAPTAF trial | |||||||||||||
Medical condition: To study the effect of catheter ablation (using CE marked products) on the quality of life an in patients with atrial fibrillation depsite treatment with conevntional antiarrhythmic medical therapy... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001795-38 | Sponsor Protocol Number: A206 | Start Date*: 2014-11-03 |
Sponsor Name:AZIENDA PROVINCIALE PER I SERVIZI SANITARI DELLA PROVINCIA AUTONOMA DI TRENTO | ||
Full Title: CRANIAL-FACIAL PAIN TREATMENT: PROSPECTIC, RANDOMIZED, OPEN-LABEL STUDY ON TRANSNASAL NONSURGICAL BLOCKADE VERSUS PHARMACOLOGICAL THERAPY | ||
Medical condition: Cranial facial pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-001567-37 | Sponsor Protocol Number: KUKIDEX-2 | Start Date*: 2016-11-24 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Efficacy of single dose intranasal dexmedetomidine for conscious sedation in dental practice in dentophobic uncooperative patients with intellectual disability. | ||
Medical condition: dentophobia intellectual disability | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-005087-93 | Sponsor Protocol Number: | Start Date*: 2006-11-17 |
Sponsor Name:East Kent Hospitals NHS Trust | ||
Full Title: A randomized double blind placebo controlled trial of Memantine in the treatment of Agitation in Alzheimers Dementia | ||
Medical condition: Alzheimers dementia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004984-11 | Sponsor Protocol Number: P150962J | Start Date*: 2018-07-06 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: "Study of maintenance of the efficacy and adverse effects of pharmacological treatments in sex offenders with paraphilia" ESPARA | |||||||||||||
Medical condition: Sexual offenders with paraphilia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004297-40 | Sponsor Protocol Number: Version 3 February 2010 | Start Date*: 2008-04-25 |
Sponsor Name:University Hospitals of Leicester NHS Trust | ||
Full Title: Pharmacological treatment of nystagmus: A randomised double masked placebo controlled crossover study using gabapentin and memantine. | ||
Medical condition: Nystagmus | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-005306-11 | Sponsor Protocol Number: SleepRCT_270215 | Start Date*: 2016-06-09 |
Sponsor Name:St. Olavs Hospital, trondheim University Hospital | ||
Full Title: Pharmacological treatment of insomnia in palliative care A randomized, double-blind, placebo controlled, parallel-group, multicenter trial investigating the short time effectiveness of zopiclone... | ||
Medical condition: The overall aim of this clinical trial is to improve the knowledge of the pharmacological treatment of insomnia in patients with advanced cancer who use opioids. Despite the high prevalence of inso... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-002289-62 | Sponsor Protocol Number: ST200-SSMA-14-001 | Start Date*: 2014-09-11 | |||||||||||
Sponsor Name:SIGMA-TAU, Industrie Farmaceutiche Riunite S.p.A. | |||||||||||||
Full Title: Electroneurographic and clinical evaluation in patients with mild / moderate Carpal Tunnel Syndrome , following conservative pharmacological treatment with Nicetile®. | |||||||||||||
Medical condition: Carpal Tunnel Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000287-17 | Sponsor Protocol Number: RC12-01 | Start Date*: 2012-05-21 | |||||||||||
Sponsor Name:FONDAZIONE SANTA LUCIA | |||||||||||||
Full Title: PROMOTION OF FUNCTIONAL RESTORATION THROUGH PHARMACOLOGICAL MODULATION OF BRAIN PLASTICITY WITH AMINOPYRIDINE IN PATIENTS WITH MULTIPLE SCLEROSIS STUDIED BY FUNCTIONAL MRI | |||||||||||||
Medical condition: Patients with MS, without relevant medical conditions, with right upper limb impairment assessed by a hand dexterity test will be included.Patients will be in a non-active phase of the disease and ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004796-39 | Sponsor Protocol Number: PT-SM-14-OA | Start Date*: 2013-04-30 | ||||||||||||||||
Sponsor Name:Fondazione IRCCS Policlinico San Matteo | ||||||||||||||||||
Full Title: A Comparative Study of Oxycodone/Naloxone versus Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Knee and/or hip Pain Due to Osteoarthritis | ||||||||||||||||||
Medical condition: Moderate to Severe Chronic Knee and/or hip Pain Due to Osteoarthritis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004548-31 | Sponsor Protocol Number: HUB-PSI-CAMAD | Start Date*: 2020-04-18 | ||||||||||||||||
Sponsor Name:Cinto Segalàs | ||||||||||||||||||
Full Title: A RANDOMIZED, CONTROLLED, OPEN AND UNICENTRIC PHASE II CLINICAL TRIAL, WITH TWO PARALLEL GROUPS, TO EVALUATE THE ANTIDEPRESSANT EFFICACY OF PSYCHOTHERAPY AND CITALOPRAM IN WOMEN DIAGNOSED WITH BREA... | ||||||||||||||||||
Medical condition: Female patients diagnosed with breast cancer who, during the first year following the diagnosis of oncological disease, have affective symptomatology that meets DSM-V criteria for major depression. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-004501-32 | Sponsor Protocol Number: NL51240.018.14 | Start Date*: 2014-12-11 |
Sponsor Name:Academic Medical Center | ||
Full Title: Infusion VErsus STimulation, a cost-effectiveness analysis of the treatment in advanced Parkinson's disease comparing Continuous Intrajejunal Levodopa Infusion to the traditional standard treetment... | ||
Medical condition: Patients with advanced PD who's motor symptoms — severe response fluctuations, dyskinesias, painful dystonia and / or bradykinesia — cannot be controlled despite optimal oral pharmacological therapy. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001066-14 | Sponsor Protocol Number: DENERVHTA | Start Date*: 2012-07-17 |
Sponsor Name:Consorci Mar Parc de salut de Barcelona ( Parc de Salut Mar) | ||
Full Title: Sympathetic renal denervation versus increment of pharmacological treatment in resistant arterial hypertension | ||
Medical condition: subjects with resistant hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000230-39 | Sponsor Protocol Number: FOG 2006 | Start Date*: 2008-04-14 |
Sponsor Name:Endocrine Society of Czech Republic | ||
Full Title: Protective effect of gonadoliberin analogues on endocrine and reproduction ovarian function during antitumour treatment in young girls and women in fertile period: Project of pharmacological gonada... | ||
Medical condition: The patient with diagnosis: Hodgkin disease and leukaemia. Patients starting at adolescence (B3 - B4 for breast development accordig Tanner criteria) till 34 years be included. ... | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Female | |
Trial protocol: CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000099-12 | Sponsor Protocol Number: APHP180617 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS | |||||||||||||
Full Title: Dose-adjustment of enoxaparin by a bayesian pharmacological approach in pediatric renal transplant recipients | |||||||||||||
Medical condition: Allograft vascular thrombosis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003370-27 | Sponsor Protocol Number: DMFMRI201303 | Start Date*: 2014-09-25 |
Sponsor Name:Rainer Rupprecht, Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg am Bezirksklinikum | ||
Full Title: Functional MRI (fMRI) after challenge and treatment with antidepressants and their relation to the clinical course, to the Hypothalamus-Hypophysis-Adrenocortical Axis and the colon microbiome | ||
Medical condition: Major Depressive Disorder is a chronic stress related disorder characterized by depressed mood and by vegetative and cognitive symptoms. Moreover, genetic, neuroendocrine and neurochemical biomarke... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003135-30 | Sponsor Protocol Number: URO-901-3005 | Start Date*: 2019-12-12 | |||||||||||
Sponsor Name:Urovant Sciences GmbH | |||||||||||||
Full Title: A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men with Overactive Bladder (OAB) Symptoms on Pharmacolog... | |||||||||||||
Medical condition: Overactive Bladder (OAB) in men with Benign Prostatic Hyperplasia (BPH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: LT (Completed) ES (Ongoing) HU (Completed) PT (Completed) BE (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.